|4Feb 27, 4:13 PM ET

SCHULMAN AMY W 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Feb 27, 2023

Insider Transaction Report

Form 4
Period: 2023-02-23
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-23+136136 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-231360 total
    Common Stock (136 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
  • [F2]This award vested on February 23, 2023, the first anniversary of the grant date.

Documents

2 files